Monique C.J. Hanse

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp et al. · The Lancet Oncology · 2014 · 753 citations

Medicine, Oncology, Pharmacotherapy +16

Transcriptome analysis reveals tumor microenvironment changes in glioblastoma

Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai et al. · Cancer Cell · 2023 · 249 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study

Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn et al. · Journal of Clinical Oncology · 2019 · 118 citations

Medicine, Molecular Medicine, Oncology +17

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate et al. · Cancer Research · 2016 · 99 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Recovery of Posterior Communicating Artery Aneurysm-Induced Oculomotor Palsy after Coiling

Monique C.J. Hanse, M.C.F. Gerrits, Willem Jan van Rooij et al. · American Journal of Neuroradiology · 2008 · 75 citations · Full text

Medicine, Neurosurgery, Surgery +17